These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36441233)

  • 1. Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry.
    Breuer J; Thomas A; Delahaut P; Schänzer W; Geyer H; Thevis M
    Anal Bioanal Chem; 2023 Feb; 415(4):669-681. PubMed ID: 36441233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
    Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
    Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
    Balcells G; Matabosch X; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control.
    Wang Z; Zhou X; Liu X; Dong Y; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-on-a-chip: Determine feasibility of a human liver microphysiological model to assess long-term steroid metabolites in sports drug testing.
    Görgens C; Ramme AP; Guddat S; Schrader Y; Winter A; Dehne EM; Horland R; Thevis M
    Drug Test Anal; 2021 Nov; 13(11-12):1921-1928. PubMed ID: 34505743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis.
    Göschl L; Gmeiner G; Gärtner P; Stadler G; Enev V; Thevis M; Schänzer W; Guddat S; Forsdahl G
    Drug Test Anal; 2021 Sep; 13(9):1668-1677. PubMed ID: 34089570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry.
    Tudela E; Deventer K; Van Eenoo P
    J Chromatogr A; 2013 May; 1292():195-200. PubMed ID: 23374366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry.
    Pozo OJ; Van Eenoo P; Deventer K; Lootens L; Grimalt S; Sancho JV; Hernández F; Meuleman P; Leroux-Roels G; Delbeke FT
    Steroids; 2009 Oct; 74(10-11):837-52. PubMed ID: 19464304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-drug interaction and doping, part 2: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of stanozolol.
    Mazzarino M; de la Torre X; Fiacco I; Botrè F
    Drug Test Anal; 2014 Oct; 6(10):969-77. PubMed ID: 24535830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
    Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
    Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Thomas A; Wachsmuth P; Orlovius AK; Sigmund G; Thevis M; Schänzer W
    J Pharm Biomed Anal; 2016 Nov; 131():482-496. PubMed ID: 27693991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a simple online-SPE method coupled to high-resolution mass spectrometry for the analysis of stanozolol-N-glucuronides in urine samples.
    Göschl L; Gmeiner G; Enev V; Kratena N; Gärtner P; Forsdahl G
    Drug Test Anal; 2020 Aug; 12(8):1031-1040. PubMed ID: 32302468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes.
    Wagener F; Guddat S; Görgens C; Angelis YS; Petrou M; Lagojda A; Kühne D; Thevis M
    Anal Bioanal Chem; 2022 Jan; 414(2):1151-1162. PubMed ID: 34734312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel dummy molecularly imprinted polymer for simultaneous solid-phase extraction of stanozolol metabolites from urine.
    Farag YG; Hanafi RS; Hammam MA
    Anal Bioanal Chem; 2024 Jun; 416(14):3335-3347. PubMed ID: 38661944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the metabolism of the selective androgen receptor modulator LGD-4033 in equine urine, plasma and hair following oral administration.
    Cutler C; Viljanto M; Hincks P; Habershon-Butcher J; Muir T; Biddle S
    Drug Test Anal; 2020 Feb; 12(2):247-260. PubMed ID: 31655494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons.
    Ahi S; Beotra A; Jain S
    Drug Test Anal; 2009 Nov; 1(11-12):538-44. PubMed ID: 20355170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.
    Thevis M; Krug O; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2017 Aug; 31(15):1290-1296. PubMed ID: 28508503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wastewater-based tracing of doping use by the general population and amateur athletes.
    Causanilles A; Nordmann V; Vughs D; Emke E; de Hon O; Hernández F; de Voogt P
    Anal Bioanal Chem; 2018 Feb; 410(6):1793-1803. PubMed ID: 29335765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.